PAPER Tremblay SA, Nathan Spreng R, Wearn A, Alasmar Z, Pirhadi A, Tardif CL, Chakravarty MM, Villeneuve S, Leppert IR, Carbonell F, Medina YI, Steele CJ, Gauthier CJ, PREVENT-AD Research Group

Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease.

Neurobiol Aging. 2025 Mar 8;150:80-96. Epub 2025 Mar 8 PubMed.

Robert Plourde

United States

Cindy Yang

United States

Katia Lopes, David Bennett on Sex Differences in Blood of Alzheimer’s and Parkinson’s Patients

COMMENT Neurodegenerative diseases such as Alzheimer's dementia and Parkinson's disease are recognized as having a significant immune component, with many studies linking alterations in the peripheral immune system to disease progression (Hammond et al.

PAPER Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A, Ellis P, Langford C, Vannberg FO, Knight JC

Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles.

Nat Genet. 2012 Mar 25;44(5):502-10. PubMed.

Lairai Chen

Beijing Normal University
China

PAPER Mu C, Shao K, Su M, Guo Y, Qiu Y, Sun R, Sun S, Sun Y, Liu C, Wang W, Qin X, Tang C

Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson's disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation.

NPJ Parkinsons Dis. 2025 Mar 15;11(1):47. PubMed.

PAPER Sabir MS, Makarious MB, Huizing M, Gahl WA, Platt FM, Malicdan MC

Comprehensive analysis of SLC17A5 variants in large European cohorts reveals no association with Parkinson's disease risk.

Parkinsonism Relat Disord. 2025 Mar 11;134:107790. Epub 2025 Mar 11 PubMed.

PAPER Thal DR, Poesen K, Vandenberghe R, De Meyer S

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.

Mol Neurodegener. 2025 Mar 14;20(1):33. PubMed.

PAPER Bhatia V, Vikram V, Chandel A, Rattan A

Interplay between PI3k/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implications.

Inflammopharmacology. 2025 Mar 15; Epub 2025 Mar 15 PubMed.

PAPER Landi B, Khoramjouy M, Lahij AG, Fazelkia S, Amidi S, Kobarfard F, Faizi M

Evaluation of the Memory Enhancement Effects of Aminopyrimidine Derivatives Using the Scopolamine Model of Dementia in Mice.

Neurotox Res. 2025 Mar 15;43(2):12. PubMed.

PAPER Bernetti C, D'Andrea V, Buoso A, Barbalace I, Greco F, Pilato F, Calandrelli R, Di Lazzaro V, Zobel BB, Mallio CA

Arterial Spin Labeling MRI in Alzheimer's Disease: A Systematic Review of Cerebral Perfusion Biomarkers.

J Neuroimaging. 2025;35(2):e70035. PubMed.

PAPER Sturno AM, Hassell JE Jr, Lanaspa MA, Bruce KD

Do microglia metabolize fructose in Alzheimer's disease?

J Neuroinflammation. 2025 Mar 15;22(1):85. PubMed.

PAPER Gao YL, Xu QH

No causal link between smoking and dementia with Lewy bodies.

Parkinsonism Relat Disord. 2025 Mar 11;:107775. Epub 2025 Mar 11 PubMed.

PAPER Mrhar A, Carballo-Casla A, Grande G, Valletta M, Fredolini C, Fratiglioni L, Gregorič Kramberger M, Kuhar A, Winblad B, Calderón-Larrañaga A, Vetrano DL

Dietary patterns and blood-based biomarkers of Alzheimer's disease in cognitively intact older adults: Findings from a population-based study.

J Prev Alzheimers Dis. 2025 Mar 14;:100124. Epub 2025 Mar 14 PubMed.